<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Maher Institute Inc</PublisherName>
      <JournalTitle>Iranian Journal of Neurodevelopmental Disorders</JournalTitle>
      <Issn>3115-848X</Issn>
      <Volume>4</Volume>
      <Issue></Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>05</Month>
        <Day>22</Day>
      </PubDate>
    </Journal>
    <ArticleTitle>Effectiveness of Dream Therapy on Anxiety in Patients with Irritable Bowel Syndrome: A Strategy to Enhance Quality of Life</ArticleTitle>
    <VernacularTitle>Effectiveness of Dream Therapy on Anxiety in Patients with Irritable Bowel Syndrome: A Strategy to Enhance Quality of Life</VernacularTitle>
    <FirstPage>1</FirstPage>
    <LastPage>7</LastPage>
    <ELocationID EIdType="doi">10.61838/kman.jndd.4.2.1</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName></FirstName>
        <LastName></LastName>
        <Affiliation></Affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName></LastName>
        <Affiliation></Affiliation>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>03</Month>
        <Day>21</Day>
      </PubDate>
    </History>
    <Abstract>&lt;p&gt;&lt;strong&gt;Purpose: &lt;/strong&gt;This study was conducted to evaluate the effectiveness of dream therapy on anxiety in patients diagnosed with Irritable Bowel Syndrome (IBS), as a strategic approach to enhancing their quality of life.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods and Materials: &lt;/strong&gt;The present research employed a semi-experimental clinical trial design with a control group. Following initial assessments and confirmation of inclusion criteria, participants were randomly assigned to two groups of 15 individuals each: an experimental group (receiving dream therapy) and a control group (waitlist). Inclusion criteria included a formal diagnosis of IBS based on the Rome III criteria, a minimum educational qualification of a high school diploma, being within the age range of 20–55 years, and scoring above the clinical cutoff on the Beck Anxiety Inventory (BAI). The experimental group received a dream therapy intervention across twelve 120-minute sessions. The measurement instrument was the Beck Anxiety Inventory (BAI), which was administered to both groups at pre-test and post-test stages. Data analysis was conducted at the level of inferential statistics using analysis of covariance (ANCOVA) via SPSS version 26.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Findings: &lt;/strong&gt;The results indicated that dream therapy significantly reduced anxiety levels in the experimental group compared to the control group (P &amp;lt; 0.005). The effect size (group effect) was reported as 0.262, with a statistical power of 0.848.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;These findings suggest that dream therapy can serve as an effective intervention for reducing anxiety in patients with Irritable Bowel Syndrome and, consequently, improving their quality of life.&lt;/p&gt;</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Dream therapy</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">anxiety</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Irritable Bowel Syndrome (IBS)</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">quality of life</Param>
      </Object>
    </ObjectList>
    <ArchiveCopySource DocType="pdf">https://maherpub.com/index.php/jndd/article/download/454/344</ArchiveCopySource>
  </Article>
</ArticleSet>
